Gut microbiota dysbiosis induces SBAs deficiency and inhibits the activation of BAs receptors FXR and TGR5, further promoting inflammation and insulin resistance (Duan et al., 2021; Sinha et al., 2020). Here, NR1H4 is linked to Insulin resistance.